Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Antibody & Protein Engineering | eBooks & Best Practices

Oxford Global's R&D Key 40 Stories 2022

24 October 2022
Download a copy of the R&D Key 40 Stories 2022 eBook today.
Read the full document

We are pleased to share with you selected highlights from Oxford Global’s content portfolios that we have been building over the past few years. In this eBook, a culmination of our efforts, we are delighted to present a variety of the most successful and widely read pieces we have released on our Biologics portal, providing you with invaluable insights into innovative biotherapeutic modalities & developments in biopharmaceutical manufacturing, through to the impact of AI/ML in biologics drug discovery.

Sample (click to enlarge)

To read the eBook in full, please click below to launch our immersive eBook reader

 

Read the full document

Related Resources

Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges

A concise report featuring insights from the prominent thought leaders of Biologics 2024
Read More

Q&A with Silvia Crescioli, Business Intelligence Creator, The Antibody Society

We catch up with Silvia Crescioli from The Antibody Society to unpack the latest trends and technologies fuelling progress in antibody therapeutic development.
Read More

Tackling Tumours from Within: Tumour Reprogramming Offers Hope in Cancer Immunotherapy

A novel gene therapy developed by Asgard Therapeutics and Lund University reprograms tumour cells into cancer-fighting immune cells.
Read More